Navigation Links
Multiple species of bacteria may cause trachoma: Implications for treatment
Date:1/2/2008

In a study published in this weeks PLoS Medicine, researchers have found that more than one species of bacteria may be causing the infectious eye disease trachoma. Six million people most of whom live in crowded and unhygienic conditions in the developing world are blind because of the disease and many more are actively infected. The possibility that multiple strains of the Chlamydiceae family of bacteria are involved in trachoma would involve a re-evaluation of vaccines and treatment programmes.

It is accepted that Chlamydia trachomatis (C. trachomatis) causes trachoma. The bacteria, some strains of which are associated with sexually transmitted infections, can also pass between people on hands and clothing; successive infections cause scarring of the inside of the eyelid. As the eyelashes of the infected eyes turn inward they scar the cornea - the transparent tissue covering the front of the eye - leading eventually to blindness. To investigate whether other species of Chlamydiceae also cause human trachoma, Deborah Dean and colleagues from Childrens Hospital Oakland Research Institute and the University of California San Francisco conducted their research in the Lumbini Zone of south-western Nepal where the disease is endemic. Obtaining specimens from 146 individuals in 9 households, they found that a third of the people who had trachoma were infected with only C. trachomatis, including not only the type that is typically described in trachoma-infected eyes but also the type usually associated with sexually transmitted diseases. Also, participants with Chlamidiacae infections of the eye were infected only with species previously associated with lung infections: one in five showed Chlamydophilia psittaci (C. psittaci) and one in ten Chlamydophila pneumoniae (C. pneumoniae); infection with these strains was just as strongly linked with severe inflammation of the eyes as was infection with the C. trachomatis bacteria already known to cause trachoma. Additionally, one third of the individuals had a mixed infection with two or three species.

Interventions to prevent trachoma by improving personal hygiene such as the SAFE initiative promoted by the World Health Organization have had limited success, and an effective vaccine may also be needed to eliminate the disease. The findings and their distribution by household and age provide evidence that C. psittaci and C. pneumoniae, in addition to C. trachomatis, are involved with trachoma and that these infections are widespread rather than sporadic. The findings would also explain why some people with active trachoma do not have C. trachomatis in their eyes, and suggest that antibiotics used for trachoma may need to be changed or used for longer periods of time to be effective against all three species. If these findings are confirmed in other trachoma-endemic regions, then future vaccines and treatments w ill need to combat all these bacteria and not just C. trachomatis.


'/>"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
Source:Eurekalert

Related biology news :

1. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
2. Nicotinic receptors may be important targets for treatment of multiple addictions
3. Emphasis on conifer forests places multiple species at risk
4. For honey bee queens, multiple mating makes a difference
5. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
6. New magnetic separation technique might detect multiple pathogens at once
7. The power of multiples: Connecting wind farms can make a more reliable - and cheaper - power source
8. New continent and species discovered in Atlantic study
9. One species entire genome discovered inside anothers
10. How the plant immune system can drive the formation of new species
11. Student study bolsters case for adding a rare sunflower to the endangered species list
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... ... launch of the Supplyframe Design Lab . Located in Pasadena, Calif., the ... future of how hardware projects are designed, built and brought to market. , ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... June 23, 2016  Blueprint Bio, a company dedicated ... the medical community, has closed its Series A funding ... . "We have received a commitment from ... we need to meet our current goals," stated ... the runway to complete validation on the current projects ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology: